Antinatriuretic action of insulin is preserved after angiotensin I converting enzyme inhibition in normal man.
To examine the potential role for intrarenal angiotensin II in mediating the antinatriuretic action of insulin, seven normal males were studied on three occasions, twice during euglycaemic hyperinsulinaemia (40 mU.m-2.min-1) after double-blind treatment for 1 week with placebo and the converting enzyme inhibitor perindopril, and on a time control day. Lithium carbonate 250 mg was given before each study as an indirect marker of tubular sodium handling. Renal haemodynamics did not change during hyperinsulinaemia. Insulin infusion reduced both the absolute and fractional urinary excretion rates of sodium (P < 0.001) and potassium (P < 0.001); these effects of insulin were not altered after converting enzyme inhibition. Lithium clearance did not change during insulin infusion on either day. The antinatriuretic effect of hyperinsulinaemia is mediated at a tubular site distal to the proximal tubule. The data does not support the hypothesis that intrarenal generation of angiotensin II plays a part in this action of insulin.
Eadington
D W
DW
Medical Renal Unit, Royal Infirmary, Edinburgh, UK.
Hepburn
D A
DA
Swainson
C P
CP
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology; D007211:Indoles / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology* / Q000502:physiology; D008094:Lithium / Q000493:pharmacokinetics; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D009318:Natriuresis / Q000187:drug effects* / Q000502:physiology; D020913:Perindopril; D012079:Renal Circulation / Q000187:drug effects / Q000502:physiology; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D001786:Blood Glucose; D007211:Indoles; D007328:Insulin; D008094:Lithium; D020913:Perindopril